{"pmid":32236624,"title":"A new threat from an old enemy: Reemergence of coronavirus (Review).","text":["A new threat from an old enemy: Reemergence of coronavirus (Review).","The new outbreak of coronavirus from December 2019 has brought attention to an old viral enemy and has raised concerns as to the ability of current protection measures and the healthcare system to handle such a threat. It has been known since the 1960s that coronaviruses can cause respiratory infections in humans; however, their epidemic potential was understood only during the past two decades. In the present review, we address current knowledge on coronaviruses from a short history to epidemiology, pathogenesis, clinical manifestation of the disease, as well as treatment and prevention strategies. Although a great amount of research and efforts have been made worldwide to prevent further outbreaks of coronavirusassociated disease, the spread and lethality of the 2019 outbreak (COVID19) is proving to be higher than previous epidemics on account of international travel density and immune naivety of the population. Only strong, joint and coordinated efforts of worldwide healthcare systems, researchers, and pharmaceutical companies and receptive national leaders will succeed in suppressing an outbreak of this scale.","Int J Mol Med","Docea, Anca Oana","Tsatsakis, Aristidis","Albulescu, Dana","Cristea, Oana","Zlatian, Ovidiu","Vinceti, Marco","Moschos, Sterghios A","Tsoukalas, Dimitris","Goumenou, Marina","Drakoulis, Nikolaos","Dumanov, Josef M","Tutelyan, Victor A","Onischenko, Gennadii G","Aschner, Michael","Spandidos, Demetrios A","Calina, Daniela","32236624"],"abstract":["The new outbreak of coronavirus from December 2019 has brought attention to an old viral enemy and has raised concerns as to the ability of current protection measures and the healthcare system to handle such a threat. It has been known since the 1960s that coronaviruses can cause respiratory infections in humans; however, their epidemic potential was understood only during the past two decades. In the present review, we address current knowledge on coronaviruses from a short history to epidemiology, pathogenesis, clinical manifestation of the disease, as well as treatment and prevention strategies. Although a great amount of research and efforts have been made worldwide to prevent further outbreaks of coronavirusassociated disease, the spread and lethality of the 2019 outbreak (COVID19) is proving to be higher than previous epidemics on account of international travel density and immune naivety of the population. Only strong, joint and coordinated efforts of worldwide healthcare systems, researchers, and pharmaceutical companies and receptive national leaders will succeed in suppressing an outbreak of this scale."],"journal":"Int J Mol Med","authors":["Docea, Anca Oana","Tsatsakis, Aristidis","Albulescu, Dana","Cristea, Oana","Zlatian, Ovidiu","Vinceti, Marco","Moschos, Sterghios A","Tsoukalas, Dimitris","Goumenou, Marina","Drakoulis, Nikolaos","Dumanov, Josef M","Tutelyan, Victor A","Onischenko, Gennadii G","Aschner, Michael","Spandidos, Demetrios A","Calina, Daniela"],"date":"2020-04-03T11:00:00Z","year":2020,"_id":"32236624","week":"202014|Mar 30 - Apr 05","doi":"10.3892/ijmm.2020.4555","source":"PubMed","topics":["Prevention"],"weight":1,"_version_":1662996001854586880,"score":7.6048946,"similar":[{"pmid":32223774,"title":"Roadblocks to Infection Prevention Efforts in Healthcare SARS-CoV-2/COVID-19 Response.","text":["Roadblocks to Infection Prevention Efforts in Healthcare SARS-CoV-2/COVID-19 Response.","The outbreak of a novel coronavirus, COVID-19, is challenging international public health and healthcare efforts. As hospitals work to acquire enough personal protective equipment and brace for potential cases, the role of infection prevention efforts and programs has become increasingly important. Lessons from the 2003 SARS-CoV outbreak in Toronto and 2015 MERS-CoV outbreak in South Korea have unveiled the critical role that hospitals play in outbreaks, especially of novel coronaviruses. Their ability to amplify the spread of disease can rapidly fuel transmission of the disease and often those failures in infection prevention and general hospital practices contribute to such events. While efforts to enhance infection prevention measures and hospital readiness are underway in the United States, it is important to understand why these programs were not able to maintain continued, sustainable levels of readiness. History has shown that infection prevention programs are primarily responsible for preparing hospitals and responding to biological events but face under-staffing and focused efforts defined by administrators. The current U.S. healthcare system though, is built upon a series of priorities that often view biopreparedness as a costly endeavor. Awareness of these competing priorities and the challenges infection prevention programs face when working to maintain biopreparedness is critical in adequately addressing this critical infrastructure in the face of an international outbreak.","Disaster Med Public Health Prep","Popescu, Saskia","32223774"],"abstract":["The outbreak of a novel coronavirus, COVID-19, is challenging international public health and healthcare efforts. As hospitals work to acquire enough personal protective equipment and brace for potential cases, the role of infection prevention efforts and programs has become increasingly important. Lessons from the 2003 SARS-CoV outbreak in Toronto and 2015 MERS-CoV outbreak in South Korea have unveiled the critical role that hospitals play in outbreaks, especially of novel coronaviruses. Their ability to amplify the spread of disease can rapidly fuel transmission of the disease and often those failures in infection prevention and general hospital practices contribute to such events. While efforts to enhance infection prevention measures and hospital readiness are underway in the United States, it is important to understand why these programs were not able to maintain continued, sustainable levels of readiness. History has shown that infection prevention programs are primarily responsible for preparing hospitals and responding to biological events but face under-staffing and focused efforts defined by administrators. The current U.S. healthcare system though, is built upon a series of priorities that often view biopreparedness as a costly endeavor. Awareness of these competing priorities and the challenges infection prevention programs face when working to maintain biopreparedness is critical in adequately addressing this critical infrastructure in the face of an international outbreak."],"journal":"Disaster Med Public Health Prep","authors":["Popescu, Saskia"],"date":"2020-04-01T11:00:00Z","year":2020,"_id":"32223774","week":"202014|Mar 30 - Apr 05","doi":"10.1017/dmp.2020.55","keywords":["biopreparedness","healthcare","hospital preparedness","infection prevention","pandemic"],"source":"PubMed","locations":["Toronto","South Korea","USA","United States"],"countries":["Canada","United States","Korea, Republic of"],"countries_codes":["CAN|Canada","USA|United States","KOR|Korea, Republic of"],"topics":["Prevention"],"weight":1,"_version_":1662819280254664706,"score":123.13052},{"pmid":32238221,"title":"Declining Public Health Protections within Autocratic Regimes: Impact on Global Public Health Security, Infectious Disease Outbreaks, Epidemics, and Pandemics.","text":["Declining Public Health Protections within Autocratic Regimes: Impact on Global Public Health Security, Infectious Disease Outbreaks, Epidemics, and Pandemics.","Public health emergencies of international concern, in the form of infectious disease outbreaks, epidemics, and pandemics, represent an increasing risk to the world's population. Management requires coordinated responses, across many disciplines and nations, and the capacity to muster proper national and global public health education, infrastructure, and prevention measures. Unfortunately, increasing numbers of nations are ruled by autocratic regimes which have characteristically failed to adopt investments in public health infrastructure, education, and prevention measures to keep pace with population growth and density. Autocratic leaders have a direct impact on health security, a direct negative impact on health, and create adverse political and economic conditions that only complicate the crisis further. This is most evident in autocratic regimes where health protections have been seriously and purposely curtailed. All autocratic regimes define public health along economic and political imperatives that are similar across borders and cultures. Autocratic regimes are seriously handicapped by sociopathic narcissistic leaders who are incapable of understanding the health consequences of infectious diseases or the impact on their population. A cross section of autocratic nations currently experiencing the impact of COVID-19 (coronavirus disease 2019) are reviewed to demonstrate the manner where self-serving regimes fail to manage health crises and place the rest of the world at increasing risk. It is time to re-address the pre-SARS (severe acute respiratory syndrome) global agendas calling for stronger strategic capacity, legal authority, support, and institutional status under World Health Organization (WHO) leadership granted by an International Health Regulations Treaty. Treaties remain the most successful means the world has in preventing, preparing for, and controlling epidemics in an increasingly globalized world.\"Honesty is worth a lot more than hope...\" The Economist, February 17, 2020.","Prehosp Disaster Med","Burkle, Frederick M","32238221"],"abstract":["Public health emergencies of international concern, in the form of infectious disease outbreaks, epidemics, and pandemics, represent an increasing risk to the world's population. Management requires coordinated responses, across many disciplines and nations, and the capacity to muster proper national and global public health education, infrastructure, and prevention measures. Unfortunately, increasing numbers of nations are ruled by autocratic regimes which have characteristically failed to adopt investments in public health infrastructure, education, and prevention measures to keep pace with population growth and density. Autocratic leaders have a direct impact on health security, a direct negative impact on health, and create adverse political and economic conditions that only complicate the crisis further. This is most evident in autocratic regimes where health protections have been seriously and purposely curtailed. All autocratic regimes define public health along economic and political imperatives that are similar across borders and cultures. Autocratic regimes are seriously handicapped by sociopathic narcissistic leaders who are incapable of understanding the health consequences of infectious diseases or the impact on their population. A cross section of autocratic nations currently experiencing the impact of COVID-19 (coronavirus disease 2019) are reviewed to demonstrate the manner where self-serving regimes fail to manage health crises and place the rest of the world at increasing risk. It is time to re-address the pre-SARS (severe acute respiratory syndrome) global agendas calling for stronger strategic capacity, legal authority, support, and institutional status under World Health Organization (WHO) leadership granted by an International Health Regulations Treaty. Treaties remain the most successful means the world has in preventing, preparing for, and controlling epidemics in an increasingly globalized world.\"Honesty is worth a lot more than hope...\" The Economist, February 17, 2020."],"journal":"Prehosp Disaster Med","authors":["Burkle, Frederick M"],"date":"2020-04-03T11:00:00Z","year":2020,"_id":"32238221","week":"202014|Mar 30 - Apr 05","doi":"10.1017/S1049023X20000424","keywords":["autocratic regimes","crisis management","epidemics/pandemics","global public health","public health emergencies"],"source":"PubMed","topics":["Prevention"],"weight":1,"_version_":1662996001892335616,"score":120.79151},{"pmid":32230900,"title":"Virology, Epidemiology, Pathogenesis, and Control of COVID-19.","text":["Virology, Epidemiology, Pathogenesis, and Control of COVID-19.","The outbreak of emerging severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) disease (COVID-19) in China has been brought to global attention and declared a pandemic by the World Health Organization (WHO) on March 11, 2020. Scientific advancements since the pandemic of severe acute respiratory syndrome (SARS) in 2002~2003 and Middle East respiratory syndrome (MERS) in 2012 have accelerated our understanding of the epidemiology and pathogenesis of SARS-CoV-2 and the development of therapeutics to treat viral infection. As no specific therapeutics and vaccines are available for disease control, the epidemic of COVID-19 is posing a great threat for global public health. To provide a comprehensive summary to public health authorities and potential readers worldwide, we detail the present understanding of COVID-19 and introduce the current state of development of measures in this review.","Viruses","Jin, Yuefei","Yang, Haiyan","Ji, Wangquan","Wu, Weidong","Chen, Shuaiyin","Zhang, Weiguo","Duan, Guangcai","32230900"],"abstract":["The outbreak of emerging severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) disease (COVID-19) in China has been brought to global attention and declared a pandemic by the World Health Organization (WHO) on March 11, 2020. Scientific advancements since the pandemic of severe acute respiratory syndrome (SARS) in 2002~2003 and Middle East respiratory syndrome (MERS) in 2012 have accelerated our understanding of the epidemiology and pathogenesis of SARS-CoV-2 and the development of therapeutics to treat viral infection. As no specific therapeutics and vaccines are available for disease control, the epidemic of COVID-19 is posing a great threat for global public health. To provide a comprehensive summary to public health authorities and potential readers worldwide, we detail the present understanding of COVID-19 and introduce the current state of development of measures in this review."],"journal":"Viruses","authors":["Jin, Yuefei","Yang, Haiyan","Ji, Wangquan","Wu, Weidong","Chen, Shuaiyin","Zhang, Weiguo","Duan, Guangcai"],"date":"2020-04-02T11:00:00Z","year":2020,"_id":"32230900","week":"202014|Mar 30 - Apr 05","doi":"10.3390/v12040372","keywords":["COVID-19","SARS-CoV-2","epidemiology","pathogenesis","therapeutics"],"source":"PubMed","locations":["China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Mechanism","Diagnosis","Transmission","Treatment"],"weight":1,"_version_":1662899337673310209,"score":117.00737},{"pmid":32098302,"title":"Emergence of Novel Coronavirus 2019-nCoV: Need for Rapid Vaccine and Biologics Development.","text":["Emergence of Novel Coronavirus 2019-nCoV: Need for Rapid Vaccine and Biologics Development.","Novel Coronavirus (2019-nCoV) is an emerging pathogen that was first identified in Wuhan, China in late December 2019. This virus is responsible for the ongoing outbreak that causes severe respiratory illness and pneumonia-like infection in humans. Due to the increasing number of cases in China and outside China, the WHO declared coronavirus as a global health emergency. Nearly 35,000 cases were reported and at least 24 other countries or territories have reported coronavirus cases as early on as February. Inter-human transmission was reported in a few countries, including the United States. Neither an effective anti-viral nor a vaccine is currently available to treat this infection. As the virus is a newly emerging pathogen, many questions remain unanswered regarding the virus's reservoirs, pathogenesis, transmissibility, and much more is unknown. The collaborative efforts of researchers are needed to fill the knowledge gaps about this new virus, to develop the proper diagnostic tools, and effective treatment to combat this infection. Recent advancements in plant biotechnology proved that plants have the ability to produce vaccines or biopharmaceuticals rapidly in a short time. In this review, the outbreak of 2019-nCoV in China, the need for rapid vaccine development, and the potential of a plant system for biopharmaceutical development are discussed.","Pathogens","Shanmugaraj, Balamurugan","Malla, Ashwini","Phoolcharoen, Waranyoo","32098302"],"abstract":["Novel Coronavirus (2019-nCoV) is an emerging pathogen that was first identified in Wuhan, China in late December 2019. This virus is responsible for the ongoing outbreak that causes severe respiratory illness and pneumonia-like infection in humans. Due to the increasing number of cases in China and outside China, the WHO declared coronavirus as a global health emergency. Nearly 35,000 cases were reported and at least 24 other countries or territories have reported coronavirus cases as early on as February. Inter-human transmission was reported in a few countries, including the United States. Neither an effective anti-viral nor a vaccine is currently available to treat this infection. As the virus is a newly emerging pathogen, many questions remain unanswered regarding the virus's reservoirs, pathogenesis, transmissibility, and much more is unknown. The collaborative efforts of researchers are needed to fill the knowledge gaps about this new virus, to develop the proper diagnostic tools, and effective treatment to combat this infection. Recent advancements in plant biotechnology proved that plants have the ability to produce vaccines or biopharmaceuticals rapidly in a short time. In this review, the outbreak of 2019-nCoV in China, the need for rapid vaccine development, and the potential of a plant system for biopharmaceutical development are discussed."],"journal":"Pathogens","authors":["Shanmugaraj, Balamurugan","Malla, Ashwini","Phoolcharoen, Waranyoo"],"date":"2020-02-27T11:00:00Z","year":2020,"_id":"32098302","week":"20209|Feb 24 - Mar 01","doi":"10.3390/pathogens9020148","keywords":["biopharmaceuticals","coronavirus","emerging threat","infectious diseases","plant system","transient expression","viruses","zoonoses"],"source":"PubMed","locations":["China","United States","Wuhan"],"countries":["China","United States"],"countries_codes":["CHN|China","USA|United States"],"topics":["Treatment"],"weight":1,"_version_":1662334544287629312,"score":114.8441},{"pmid":32129581,"title":"[Prediction modeling with data fusion and prevention strategy analysis for the COVID-19 outbreak].","text":["[Prediction modeling with data fusion and prevention strategy analysis for the COVID-19 outbreak].","Since December 2019, the outbreak of COVID-19 in Wuhan has spread rapidly due to population movement during the Spring Festival holidays. Since January 23rd, 2020, the strategies of containment and contact tracing followed by quarantine and isolation has been implemented extensively in mainland China, and the rates of detection and confirmation have been continuously increased, which have effectively suppressed the rapid spread of the epidemic. In the early stage of the outbreak of COVID-19, it is of great practical significance to analyze the transmission risk of the epidemic and evaluate the effectiveness and timeliness of prevention and control strategies by using mathematical models and combining with a small amount of real-time updated multi-source data. On the basis of our previous research, we systematically introduce how to establish the transmission dynamic models in line with current Chinese prevention and control strategies step by step, according to the different epidemic stages and the improvement of the data. By summarized our modelling and assessing ideas, the model formulations vary from autonomous to non-autonomous dynamic systems, the risk assessment index changes from the basic regeneration number to the effective regeneration number, and the epidemic development and assessment evolve from the early SEIHR transmission model-based dynamics to the recent dynamics which are mainly associated with the variation of the isolated and suspected population sizes.","Zhonghua Liu Xing Bing Xue Za Zhi","Tang, S Y","Xiao, Y N","Peng, Z H","Shen, H B","32129581"],"abstract":["Since December 2019, the outbreak of COVID-19 in Wuhan has spread rapidly due to population movement during the Spring Festival holidays. Since January 23rd, 2020, the strategies of containment and contact tracing followed by quarantine and isolation has been implemented extensively in mainland China, and the rates of detection and confirmation have been continuously increased, which have effectively suppressed the rapid spread of the epidemic. In the early stage of the outbreak of COVID-19, it is of great practical significance to analyze the transmission risk of the epidemic and evaluate the effectiveness and timeliness of prevention and control strategies by using mathematical models and combining with a small amount of real-time updated multi-source data. On the basis of our previous research, we systematically introduce how to establish the transmission dynamic models in line with current Chinese prevention and control strategies step by step, according to the different epidemic stages and the improvement of the data. By summarized our modelling and assessing ideas, the model formulations vary from autonomous to non-autonomous dynamic systems, the risk assessment index changes from the basic regeneration number to the effective regeneration number, and the epidemic development and assessment evolve from the early SEIHR transmission model-based dynamics to the recent dynamics which are mainly associated with the variation of the isolated and suspected population sizes."],"journal":"Zhonghua Liu Xing Bing Xue Za Zhi","authors":["Tang, S Y","Xiao, Y N","Peng, Z H","Shen, H B"],"date":"2020-03-05T11:00:00Z","year":2020,"_id":"32129581","week":"202010|Mar 02 - Mar 08","doi":"10.3760/cma.j.cn112338-20200216-00107","keywords":["COVID-19","Dynamical model","Reproductive number"],"source":"PubMed","locations":["China","Chinese","Wuhan"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Epidemic Forecasting","Transmission","Prevention"],"weight":1,"_version_":1662334544024436737,"score":111.57986}]}